Department of Pediatrics, Division of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine
Rachel Linnemann, MD, is a pediatric pulmonologist and Associate Professor of Pediatrics at Emory University. She is the Director of the Children's Healthcare of Atlanta and Emory University CF Care Center and Co-Director of the Emory CF Therapeutic Development Center. She has previously served on the TDN Steering Committee and Protocol Review Committee. She was a national co-leader of the modulator quality improvement innovation lab in the CF Learning Network, and she leads the CF Subcommittee of the Georgia Newborn Screening and Genetics Advisory Committee. Her research interests include CF clinical trials, CFTR modulator theratyping, quality improvement, and newborn screening. She received her M.D. from Yale University and completed her residency in pediatrics and fellowship in pediatric pulmonology at Massachusetts General Hospital.
W15--New Horizons in CF Newborn Screening: Advancements & Updates
Thursday, October 23, 2025
10:15 AM - 12:15 PM PDT
Friday, October 24, 2025
2:30 PM - 4:00 PM PDT
S19.3- Sweat Signals: Use of Sweat Chloride in Clinical Trials of CFTR Modulators
Friday, October 24, 2025
2:30 PM - 4:30 PM PDT